Analgesics market seen reaching $132.6 billion by 2030

By AI, Created 10:19 AM UTC, May 20, 2026, /AGP/ – The Business Research Company projects the global analgesics market will rise from $113.1 billion in 2025 to $132.6 billion by 2030, driven by healthcare spending, aging populations and demand for pain treatments. North America led the market in 2025, while the Middle East is expected to grow fastest through 2030.

Why it matters: - The analgesics market is tied to demand for pain relief across surgery, cancer care, trauma treatment and chronic conditions. - Growth in the market points to higher spending on pharmaceuticals, more use of digital care channels and continued development of opioid alternatives. - The report highlights a shift toward personalized pain management and safer use of analgesic drugs.

What happened: - The Business Research Company released its Analgesics Global Market Report 2026 – Market Size, Trends, And Forecast 2026-2035 on May 7, 2026. - The report values the global analgesics market at $113.1 billion in 2025 and projects $115.82 billion in 2026. - The report forecasts the market will reach $132.6 billion by 2030, at a 3.4% CAGR over the forecast period. - The company published a free sample of the report and the full market report.

The details: - Historical growth was driven by more musculoskeletal disorders, more surgical procedures, more cancer cases, expanded hospital infrastructure and widespread access to generic analgesics. - Future growth is expected to come from personalized medicine, R&D on opioid alternatives, e-pharmacies, digital healthcare platforms, an aging population and smart manufacturing in pharmaceuticals. - The report expects more personalized pain management solutions, growth in both opioid and non-opioid analgesics, expansion of hospital and retail pharmacy channels, stronger demand for chronic and cancer pain treatment, and greater awareness of safe analgesic use. - Analgesics are medications used to relieve pain, including musculoskeletal pain, post-surgical discomfort, trauma-related pain and cancer-associated pain. - Common analgesics include codeine, hydrocodone, oxycodone and methadone. - Rising healthcare spending is a major growth driver because it supports pharmaceutical R&D and new drug development. - The UK Office for National Statistics reported a 5.6% nominal increase in total healthcare spending from 2022 to 2023 in May 2024. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - North America held the largest share of the global analgesics market in 2025. - The Middle East is projected to post the fastest growth rate during the forecast period.

Between the lines: - The forecast suggests the analgesics category is evolving from a mature pain-relief market into one shaped by precision medicine, digital distribution and safety concerns around opioids. - The emphasis on non-opioid development reflects broader pressure on the pharmaceutical industry to offer alternatives in pain care. - Regional growth patterns show the market is still concentrated in North America, but expansion opportunities are widening in faster-growing regions.

What’s next: - Analysts and investors will likely watch whether growth in e-pharmacies, chronic pain treatment and personalized therapies can lift the market closer to the 2030 forecast. - The report points to continued product development across opioid and non-opioid segments as the clearest near-term opportunity. - More market coverage is available through related reports on pain management drugs and anesthetics.

The bottom line: - The analgesics market is projected to keep growing steadily, with healthcare spending and innovation in pain treatment driving the next phase of expansion.